How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
A QUOTIDIAN COURSE
Among the many issues facing both the imaging markets and business in general is a process coined in government circles more recently as ?connecting the dots.? Perhaps the truth about how the imaging markets are growing or declining lies beyond connecting the dots and a sphere of penumbras related to paranoia. While competing vendors may be at your path to profitability, they were always there. The poet Cavafy wrote ?What's going to happen to us without barbarians (competitors)? They were, those people, a kind of solution.? Being at the gates of your marketplace is a good place to keep them.
Skepticism is a growth industry today. It seems that all a vendor has to do today is take a few facts, embellish them with a subliminal message and although the narrative may seem to be plausible, it is truly not verifiable unless it can be tested against a ?real? standard. The interactive world faces a similar dilemma without standards. For many people, being online is therapeutic, albeit a rather simplistic way to calm anxieties about a complicated world.
We need the technical standards to deliver the goods to the unconnected dots of the imaging market. I personally have signed up as a consultant to three separate standards initiatives: DOD IR for Motion Imagery, 3DIF and WEB 3D.org for 3D file formats and a new venture to bring together the 3D medical community for training, education and surgical procedures. This data will accessible on the web site www.roimarkets.com, since this venture falls outside of the commercial properties of this magazine.
Advanced Imaging grew up when major corporations were funding consultants like me and others to determine what would be the impact of electronic imaging on their core products. These companies included the likes of Kodak, Dupont, GE and many others. Today, we are about to add more chemical and biomedical imaging market opportunities to the growing list of image-enabled solutions. Next month, Mike May, whose credentials include a Ph.D. in neurobiology and behavior, an M.S. in biological engineering and a B.A. in biology, and numerous articles in such widely read publications as Scientific American and Microsoft's Encarta , will begin a three-part series on the role of imaging in the biomedical markets from the research, application and opportunity point of view.
Chemical imaging enters the market segment from the acquisition of images across a contiguous series of narrow spectral band, which is comparable to spectroscopy techniques. What's more, chemical imaging is being used more widely in pharmaceutical imaging since traditional analytical methods are unable to detect defects in the process. The complete process would include a fast analytical process to deliver spatial, chemical, structural and fundamental information. These dots will never connect to machine vision since machine vision does not include the visualization mandatory for three-dimensional data spanning one wavelength and two spatial dimensions.